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Objective: To evaluate the correlation between ARFI and Child-Pugh classification. Secondary 
Aims: 1) To compare ARFI values (hepatic, splenic and spleno-hepatic index) from cirrhotic to 
normal population; 2) To correlate biochemical parameters of liver function and ARFI. Materials 
and Methods: 58 cirrhotic patients (referenced to US for surveillance or to clarify any hepatic de-
compensation) were included in this prospective study, as well as 38 healthy subjects who under-
went ultrasonography for other reasons than hepatic evaluation. All had ARFI liver and spleen 
evaluation on ACUSON S2000 ARFI equipment. The best cut-off liver and spleen values for the di-
agnosis of cirrhosis in comparison to the normal subjects were determined using SPSS® v20. Re-
sults: Mean liver ARFI values in controls and cirrhotic patients were respectively 1.18 ± 0.22 m/s 
and 2.93 ± 0.50 m/s. The ROC curve demonstrated an AUC 0.998 and the best cut-off was 1.89. 
Mean spleen ARFI values in controls and cirrhotic patients were respectively 2.60 ± 0.42 m/s and 
3.03 ± 0.71. The ROC curve demonstrated an AUC 0.766 and the best cut-off was 2.73 m/s. The 
splenohepatic index showed a worse AUC than ARFI liver. A weak correlation was found between 
the ARFI liver and Child-Pugh. We found no statistically significant differences for spleen ARFI 
values and Child-Pugh. We found a statistically significant correlation between liver ARFI and bi-
lirubin, ALKP, GGT, AST and AST/ALT ratio; and with spleen ARFI and ALKP and AST/ALT ratio. 
Conclusion: We showed that there is a tendency of higher levels of liver ARFI values for higher 
Child-Pugh classification suggesting a definite trend for higher values with more severe disease. 
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Cirrhosis is a commonly encountered chronic liver disease characterized by the deposition of fibrous tissue 
within the liver. This causes the liver to become stiffer than normal, with distortion of normal liver architecture 
[1]. 
A precise estimation of the degree of liver fibrosis is important for the estimation of prognosis, surveillance, 
and treatment decision in patients with chronic liver disease [2] [3]. 
Biopsy provides an extremely valuable contribution to the assessment of liver status in the case of chronic 
disease, offering information both on fibrosis and necro-inflammatory activity. However, not only the risk of 
complications, which has been reported with a frequency of 5% - 20% for minor complications and 0.3% - 0.5% 
for major complications [4] including exceptional cases of mortality, but also contraindications, such as coagu-
lopathy, large volume ascitis, poor patient cooperation and lack of patient consent, tend to limit its use, espe-
cially for repeated procedures over time [5]. 
Acoustic Radiation Force Impulse (ARFI) imaging Virtual TouchTM tissue quantification uses a software of 
the US Scanners Siemens Acuson S2000 (Siemens Healthcare, Erlangen, Germany) that offers the possibility of 
performing a quantitative measurement of the elasticity of the hepatic parenchyma during conventional US eva- 
luations [6]. ARFI imaging technology involves the mechanical excitation of tissue using short-duration acoustic 
pulses in a region of interest chosen by the examiner, producing shear waves that spread away from the region 
of interest, generating localized, micron-scale displacements in the tissue [7] [8]. By recording the shear wave 
front at several locations and correlating these measurements with the elapsed time, the shear wave velocity (m/s) 
can be quantified; generally, the stiffer is a region in the tissue; the shear wave velocity will be greater as it tra-
vels through this region [9]-[12]. 
The Child-Pugh Score stratifies the severity of cirrhosis (from class A—better prognosis to class C—worst 
prognosis), and predicts the probability of decompensation and death, using clinical and analytical data (ascitis, 
encephalopathy, total bilirubin, serum albumin and international normalized ratio or prothrombin time). Origi-
nally, the Child-Pugh Score was used to predict mortality during surgery; however it is now used to assess 
prognosis and to evaluate the need of liver transplantation. 
The primary aim of this study was to evaluate the correlation between ARFI results and Child-Pugh classifi-
cation. Secondary aims were 1) to compare ARFI values (hepatic, splenic and spleno-hepatic index) from cirr-
hotic to normal population and 2) to correlate biochemical parameters of liver function and ARFI. 
2. Methods and Materials 
2.1. Subjects 
We obtained written informed consent from all the subjects in the study and the approval of the Hospital Ethics 
Committee. 
In this prospective study 96 examinees were categorized into two groups: 1) 58 patients with previously di-
agnosed liver cirrhosis (biopsy-proven cirrhosis or clinically presumed cirrhosis—combination of clinical, ana-
lytical, endoscopic and imaging data); 2) 38 healthy individuals, with no hepatic disease, who undergone ultra-
sonography study for various reasons—abdominal pain, vomiting, renal colic and some volunteer members of 
hospital staff (the inclusion criteria were no history of liver disease, no diseases such as diabetes, renal insuffi-
ciency, and congestive heart failure, and laboratory tests done within 30 days. The exclusion criteria were age 
under 18 years old, use of chronic medication and refusal to participate in the study); 
Diagnosis of cirrhosis by non-invasive imaging, including ultrasound, magnetic resonance or a combination 
of the two, was established based on typical imaging findings, including liver surface nodularity, liver segment I 
hypertrophy, splenomegaly, hepatofugal portal venous flow and portosystemic vascular shunts. The exclusion 
criteria were: no laboratory tests done within 30 days and portal vein thrombosis. 
The 58 cirrhotic patients were categorized using the Child-Pugh classification: Child A (34, 58.6%), Child B 
(13, 22.4%), Child C (10, 19%). 
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Etiology of liver cirrhosis included alcohol (n = 47, 81%), hepatitis B virus (HBV) infection (n = 4, 6.9%), 
hepatitis C virus (HCV) infection (n = 4, 6.9%) and primary biliary cirrhosis (PBC) (n = 3, 5.2%). 
Demographic data, including age and gender were recorded for each individual patient at the time of ARFI 
imaging. 
2.2. Acoustic Radiation Force Impulse Imaging Examination 
All participants (n = 96) were examined using the Siemens ACUSON S2000 Ultrasound ARFI Virtual TouchTM 
Tissue Quantification System (Erlangen, Germany). During real-time B-mode imaging, a region-of-interest was 
placed in right hepatic lobe or the spleen on vessel- and tumor-free parenchyma, at a depth of 2 - 8 cm, during 
suspended respiration (Figure 1(a) and Figure 1(b)). In 6 hours fasting examinees, six measurements were per-
formed from both referenced organs. The final ARFI value for each participant and for each organ was calcu-
lated as a mean of these 6 measurements. We used a 4 MHz convex probe that applies short duration acoustic 
pulses with a fixed transmitter frequency to generate localized displacements in tissue. The results are expressed 
in meters per second (m/s). 
ARFI values in m/s obtained in the liver were multiplied by those of the spleen and divided by 100, producing 
the spleno-hepatic index. 
2.3. Biochemical Parameters of Liver Function 
The following biological parameters were recorded in each individual patient at the same month of ARFI ex-
amination: total bilirubin (Bilirubin) (µmol/L), alkaline phosphatase (ALKP) (U/L), γ-glutamyl transpeptidase 
(GGT) (U/L), aspartate aminotransferase (AST) (U/L) and alanine aminotransferase (ALT) (U/L). We calcu-
lated also the AST/ALT ratio. 
2.4. Statistical Analysis 
Statistical analysis was performed using the Statistical Package for Social Sciences software (IBM SPSS Statis-
tics for Windows, Version 20.0. Armonk, NY: IBM Corp.). The verification of the assumptions of normality for 
the application of parametric tests on the variables of interest was done resorting to the Kolmogorov-Smirnov 
test with Lilliefors correction. Non-parametric tests were performed whenever normality could not be assumed. 
All tests were two-tailed and a p-value of less than 0.05 was deemed to be statistically significant. 
For ARFI imaging, the mean of 6 successful measurements obtained in each patient for liver and for spleen 
was calculated and used for further analyses. Overall comparison of ARFI liver and spleen values between dif-
ferent Child-Pugh classification groups performed using the Mann-Whitney U-test. These results were expressed 
as mean ± standard deviation for the sake of comparability with published data. Laboratory tests were compared 
using the Mann-Whitney U-test and the results were expressed as median (range). 
For the purpose of evaluating the performance of hepatic fibrosis tests in predicting cirrhosis, using clinical 
assessment as the gold standard, ROC analyses were performed. This included the calculation of the area under 
the ROC curves (AUC), as well as related sensitivity (Se) and specificity (Sp) values. 
 
 
\Figure 1. ARFI measurements in a cirrhotic patient. (A) Right liver lobe; (B) Spleen.           
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The Spearman correlation between Child-Pugh classification and ARFI measurements for liver and spleen 
was calculated only for cirrhotic patients. 
The chi-square test was used to compare categorical variables, expressed as percentages. Logistic regression 
analysis was used to confirm predictors of cirrhosis while removing the nuisance influence of sex and age.  
3. Results 
3.1. Patient Population Characteristics 
In total 96 consecutive patients were evaluated by ARFI. ARFI was able to provide valid results in all of these 
patients. The etiology of liver disease (alcohol, HBV, HCV and PBC) and other patient characteristics are listed 
in Table 1. 
58 cirrhotic patients (A) and 38 healthy individuals (B), were included in the study. Mean age for group A 
was 65.5 ± 11.8 and for group B was 56.7 ± 16.3. As expected, the patients with liver cirrhosis were older com-
pared to the other group. In the group A 73.9% were male and 19.4% were female, while in group B 34.2% were 
male and 65.8% were female. 
There was a significant difference for age and gender between the two groups; however, applying a logistic 
regression, we found that these differences do not interfere in the predictive capability of ARFI liver and spleen 
values. 
We found statistically differences between the serum markers results of the two groups (healthy and cirrhotic), 
with exception for ALT (Table 2). 
3.2. ARFI Liver Values 
Six ARFI values were successfully obtained from the right lobe of the liver in all 96 patients. 
There was a significant difference in the ARFI hepatic values between the two groups. The mean ARFI he-
patic values of cirrhotic and healthy groups were 2.93 ± 0.50 m/s and 1.18 ± 0.22 m/s, respectively (p < 0.001) 
(Figure 2 and Table 3). The ROC curve analysis demonstrated an AUC of 0.998 (95% Confidence Interval 
0.994 - 1.000). The best cut-off for establishing the presence of cirrhosis proved to be 1.89 m/s for liver values 
(98.3% Se and 100% Sp). 
3.3. ARFI Spleen Values 
Six ARFI values were successfully obtained from the spleen of all 96 patients, regardless of splenic size (whe- 
ther normal or enlarged). The mean ARFI spleen values were 2.60 ± 0.42 m/s in normal subjects and 3.03 ± 0.71 
 
Table 1. Patients characteristics, values are expressed as mean ± SD or n (%).                                        
 Cirrhosis (A) Healthy (B) p 
N 58 38  
Age (yrs) 65.5 ± 11.8 56.7 ± 16.3 p = 0.003* 
Gender (M:F) M: 73.9%; F: 19.4% 51:7 
M: 34.2%; F: 65.8% 
13:25 p < 0.001** 
Etiology of liver disease    
Alcohol 47 (81%)   
HBV 4 (6.9%)   
HCV 4 (6.9%)   
PBC 3 (5.2%)   
Child-Pugh classification    
A 34 (58.6%)   
B 13 (22.4%)   
C 10 (19%)   
*t-Test; **Test chi-square (F—female; HBV—hepatitis B virus; HCV—hepatitis C virus; M—male; PBC—primary biliary cirrhosis). 
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Table 2. Laboratory tests results of healthy and cirrhotic patients. Results are express as median and min-max.              
 Cirrhosis (A) Healthy (B) p 
Bilirubin (µmol/L) 20.5 (7.0 - 4539) 9.5 (3.8 - 34.4) p < 0.001* 
ALKP (U/L) 109 (39 - 387) 65.5 (41 - 146) p < 0.001* 
GGT (U/L) 92.5 (13 - 647) 22 (10 - 163) p < 0.001* 
AST (U/L) 41 (18 - 273) 27 (13 - 56) p < 0.001* 
ALT (U/L) 35 (10 - 220) 30 (12 - 63) p = 0.259* 
AST/ALT 1.1 (0.32 - 4.88) 0.9 (0.39 - 1.44) p = 0.001* 
*Mann Whitney test (ALKP—alkaline phosphatase; ALT—alanine aminotransferase; AST—aspartate aminotransferase; Bilirubin—total bilirubin; 
GGT—γ-glutamyl transpeptidase). 
 
Table 3. Liver and splenic stiffness values in healthy and cirrhotic patients. Values are expressed as mean ± SD.             
 Cirrhosis (A) Healthy (B) p 
ARFI Liver (m/s) 2.93 ± 0.50 1.18 ± 0.22 p < 0.001* 
ARFI Spleen (m/s) 3.03 ± 0.71 2.60 ± 0.42 p < 0.001* 
*Mann Whitney test. 
 
 
Figure 2. Box plots of liver ARFI values obtained in healthy 
and cirrhotic patients. A significant difference between healthy 
and cirrhotic was observed (p < 0.001).                      
 
in cirrhotic patients. 
We observed a statistically significant difference between ARFI spleen values in subjects without hepatic pa-
thology and those with liver cirrhosis (p < 0.001) (Figure 3 and Table 3). The ROC curve analysis demonstrat-
ed an AUC of 0.766 (95% Confidence Interval 0.671 - 0.862). The best cut-off for establishing the presence of 
cirrhosis proved to be 2.73 m/s for spleen values (78.9% Se and 65.8% Sp). 
3.4. Spleno-Hepatic Index 
We calculated the spleno-hepatic index (liver ARFI values multiplied by splenic values divided by 100) and 
concluded that the AUC for this index is subtle worse than AUC ARFI liver (data not shown). 
3.5. Correlation between ARFI and Child-Pugh Classification 
We studied 34 patients in Child-Pugh A group, 13 in Child-Pugh B and 10 in Child-Pugh C (Table 1). The 
mean ARFI liver values were 2.83 ± 0.54 m/s, 2.95 ± 0.40 and 3.24 ± 0.46, respectively. A weak Spearman cor-
relation was found between the ARFI liver values and the Child-Pugh classification (ρ = 0.280; p = 0.039) 
(Figure 4). 
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Figure 3. Box plots of spleen ARFI values obtained in healthy 
and cirrhotic patients. A significant difference between healthy 
and cirrhotic was observed (p < 0.001).                      
 
 
Figure 4. Column chart of liver ARFI mean values obtained in 
cirrhotic patients, classified in A, B and C of Child-Pugh classi-
fication. Error bars represent 1 standard deviation. A weak li-
near correlation was found between the ARFI liver values and 
the Child-Pugh classification.                             
 
On a closer inspection, there were no statistically significant correlation between spleen ARFI values and the 
Child-Pugh classification. 
3.6. Correlation between ARFI and Biochemical Parameters of Liver Function 
We examined the correlation between the ARFI liver and spleen values and results from laboratory tests (Table 
4). We found that there is a statistically significant direct correlation between liver ARFI values and the labora-
tory results of bilirubin, ALKP, GGT, AST and AST/ALT ratio. In what concerns to spleen, we found a statisti-
cally significant direct correlation between the ARFI values and ALKP and AST/ALT ratio. 
4. Discussion 
Our results were consistent with those found on recent literature (Table 5). 
Yu et al. [1] and Piscaglia et al. [5] compared ARFI liver values in normal and cirrhotic patients. Yu deter- 
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Table 4. Correlation between ARFI results and laboratory tests results.       
 ARFI liver ARFI spleen 
Bilirubin ρ = 0.528 p < 0.001 
ρ = 0.210 
p = 0.060 
ALKP ρ = 0.529 p < 0.001 
ρ = 0.369 
p = 0.001 
GGT ρ = 0.479 p < 0.001 
ρ = 0.160 
p = 0.171 
AST ρ = 0.395 p < 0.001 
ρ = 0.168 
p = 0.129 
ALT ρ = 0.084 p = 0.455 
ρ = 0.003 
p = 0.980 
AST/ALT ρ = 0.367 p < 0.001 
ρ = 0.250 
p < 0.05 
ρ—Spearman correlation coefficient; ALKP—alkaline phosphatase; ALT—alanine amino-
transferase; AST—aspartate aminotransferase; Bilirubin—total bilirubin; GGT—γ-glutamyl 
transpeptidase. 
 
Table 5. Comparison between our results and previous studies results.                                              
  ARFI Liver (m/s) ARFI Spleen (m/s) 
  Normal Cirrhotic Normal Cirrhotic 
A. Gallotti [13] 2010 1.59 - 2.44 - 
Simona Bota [14] 2010 - - 
2.04 ± 0.28 3.10 ± 0.55 
AUC 0.91, cut-off 2.51 
(Se 85.2%; Sp 91.7%) 
F. Piscaglia [5] 2011 
1.13 2.55 
- - AUC 0.941, cut-off 1.75 
(Se 93%; Sp 85.1%) 
I. Grgurevic [16] 2011 
1.13 ± 0.13 2.77 ± 0.68 2.27 ± 0.35 3.29 ± 0.65 
- AUC 0.822, cut-off 2.73 (Se 90%; Sp 77.8%) 
K. Rifai [17] 2011 1.09 ± 0.18 2.55 ± 1.02 2.86 ± 0.58 3.25 ± 0.56 
Hojun Yu [1] 2012 
1.16 ± 0.34 2.35 ± 0.70 
- - AUC 0.932, cut-off 1.36 
(Se 88%; Sp 90%) 
Vermehren J. [20] 2012 - 3.01 ± 0.99 - 3.64 ± 0.88 
Yoshitaka Takuma [15] 2013 1.21 2.58 2.16 3.36 
Our study 2013 
1.18 ± 0.22 2.93 ± 0.50 2.60 ± 0.42 3.03 ± 0.71 
AUC 0.998, cut-off 1.89 
(Se 98.3%; Sp 100%) 
AUC 0.766, cut-off 2.73 
(Se 78.9%; Sp 65.8%) 
AUC—area under curve; Se—sensitivity; Sp—specificity. 
 
mine 1.13 m/s for healthy and 2.55 m/s for cirrhosis and Piscaglia determined 1.16 for healthy and 2.35 m/s for 
cirrhotic patients. Our study found values slightly higher than those. 
Gallotti et al. [13] performed the first measurements of the abdominal organs stiffness evaluating 35 healthy 
volunteers, the mean values being 1.59 m/s for liver and 2.44 m/s for spleen. In our study we obtained lower 
values for liver in patients without liver pathology (1.18 ± 0.22) and slightly higher spleen values (2.60 ± 0.42) 
for the same health group. 
Bota et al. [14] used ARFI to determine ARFI spleen values in cirrhotic patients and its use in predicting the 
presence of portal hypertension signs (esophageal varices). The study included 57 cirrhotic patients and for a 
cut-off value of 2.51 m/s (AUROC 0.91, p < 0.0001, with 85.2% Se, 91.7% Sp, 95.8% PPV, 73.3% NPV and 
87.1% accuracy). Thus confirming the hypothesis that an increase in splenic stiffness occurs with the develop-
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ment of portal hypertension. In our study, we obtained slightly higher values for spleen values in cirrhotic pa-
tients (3.03 ± 0.71). 
Takuma et al. [15], Grgurevic et al. [16] and Rifai et al. [17] evaluated ARFI of the liver and the spleen of 
groups of healthy and cirrhotic patients. As our study, all obtained significant higher ARFI values for both or-
gans in cirrhotic patients (for ARFI liver values the results were respectively 1.21 m/s, 1.13 ± 0.13 m/s, 1.09 ± 
0.18 m/s for healthy and 2.16 m/s, 2.27 ± 0.35 m/s, 2.86 ± 0.58 m/s for cirrhotic and for ARFI spleen values the 
results were respectively 2.58 m/s, 2.77 ± 0.68 m/s, 2.55 ± 1.02 m/s for healthy and 3.36 m/s, 3.29 ± 0.65 m/s, 
3.25 ± 0.56 for cirrhotic). 
Spleno-hepatic index has been studied in same literature [18] [19] and had found same contradictory results. 
Our results showed that, when we combine the 2 values of ARFI (hepatic and splenic) in that index, we do not 
find a better AUC for the diagnosis of cirrhosis. 
Vermehren et al. [20] performed a study with 166 cirrhotic patients and correlate, among other hypothesis, the 
correlation between hepatic and splenic ARFI and the prediction of Child-Pugh B/C vs. A. They concluded that 
there were significant overall differences between those clinical groups. In our study, we found that there is a 
tendency of higher levels of liver ARFI values for higher the Child-Pugh classification (A to B and B to C), 
suggesting a definite trend for higher values with more severe disease. 
ARFI also produced results correlated with those obtained laboratory tests: there was a statistically significant 
direct correlation between liver ARFI values and the laboratory results of bilirubin, ALKP, GGT, AST and 
AST/ALT ratio and a statistically significant direct correlation between the spleen ARFI and ALKP and 
AST/ALT ratio. 
Furthermore, an advantage of using both techniques (B mode and ARFI) is that they are fast and convenient 
to perform and use a conventional US machine. Moreover, ultrasound permits the evaluation of other features 
such as portal vein diameter, splenomegaly and liver surface, which has been shown to be highly accurate in the 
diagnosis of early cirrhosis and seems to provide complementary information to that of liver stiffness. 
The limitations of our study include the following: unavoidable selection bias caused by clinical diagnosis of 
cirrhosis without a liver biopsy; a single center study without external validation.  
5. Conclusions 
In the present study, we have found that ARFI showed excellent accuracy to determine the presence of cirrhosis. 
We also found that liver ARFI was better than both spleen ARFI and spleno-hepatic index for the diagnosis of 
cirrhosis. 
We showed that there is a tendency of higher levels of liver ARFI values for higher Child-Pugh classification 
suggesting a definite trend for higher values with more severe disease. 
We found that there is a statistically significant direct correlation between liver ARFI values and the labora-
tory results of bilirubin, ALKP, GGT, AST and AST/ALT ratio. In what concerns spleen ARFI values, we found 
a statistically significant direct correlation between the ARFI and ALKP and AST/ALT ratio. 
According to the limitations mentioned, further studies are needed to overcome them, with a larger number of 
cirrhotic patients that will provide us with a cut-off between the groups of this classification, as a good diagnos-
tic tool for the prediction of worse prognosis that will help in clinical practice. 
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ARFI—Acoustic Radiation Force Impulse 
AST—Aspartate Aminotransferase 
AUC—Area under Curve 
Bilirubin—Total Bilirubin 
GGT—γ-Glutamyl Transpeptidase 
HBV—Hepatitis B Virus 
HCV—Hepatitis C Virus 
PBC—Primary Biliary Cirrhosis 
Se—Sensitivity 
Sp—Specificity 
